socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Monday, March 24, 2008

    Trius Therapeutics Raises $30M
    San Diego-based Trius Therapeutics said today that it has raised $30M in a Series B funding round. The funding was led by Kleiner, Perkins, Caulfied and Byers. FinTech Global Capital, a new investor in the firm, also participated, along with existing backers Sofinnova Ventures, Versant Ventures, Interwest Partners and Prism VentureWorks. Trius Therapeutics is developing antibacterial drugs.
    posted on Monday, March 24, 2008 (Link to more information)

    Related companies:
    Trius Therapeutics

    Related stories:
    > Trius Therapeutics Finds $20M
    > NovaDigm Therapeutics Raises $4M
    > Tobira Therapeutics Raises $31M
    > MabVax Therapeutics Raises $8M For Cancer Treatment
    > Invitrogen Invests In Q Therapeutics

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, September 5, 2008
    Thursday, September 4, 2008
    Wednesday, September 3, 2008
    Tuesday, September 2, 2008
    Friday, August 29, 2008